C
Clarity Pharmaceuticals Ltd
ASX:CU6
Clarity Pharmaceuticals Ltd
ASX:CU6
Price:
2.915
AUD
-5.36%
Market Closed
Market Cap:
AU$1.1B
Income Statement
Earnings Waterfall
Clarity Pharmaceuticals Ltd
Clarity Pharmaceuticals Ltd
Income Statement
Clarity Pharmaceuticals Ltd
Clarity Pharmaceuticals Ltd
Currency: AUD
| Jun-2023 | Dec-2023 | Jun-2024 | Dec-2024 | Jun-2025 | ||
|---|---|---|---|---|---|---|
| Revenue | ||||||
| Revenue |
12
N/A
|
12
+1%
|
0
N/A
|
0
N/A
|
0
N/A
|
|
| Operating Income | ||||||
| Operating Expenses |
(26)
|
(33)
|
(45)
|
(56)
|
(69)
|
|
| Selling, General & Administrative |
(5)
|
(6)
|
(10)
|
(12)
|
(11)
|
|
| Research & Development |
(31)
|
(36)
|
(46)
|
(55)
|
(67)
|
|
| Depreciation & Amortization |
0
|
(0)
|
(0)
|
(0)
|
(0)
|
|
| Other Operating Expenses |
10
|
9
|
12
|
11
|
9
|
|
| Operating Income |
(26)
N/A
|
(33)
-24%
|
(45)
-37%
|
(56)
-26%
|
(69)
-23%
|
|
| Pre-Tax Income | ||||||
| Interest Income Expense |
2
|
2
|
3
|
8
|
5
|
|
| Pre-Tax Income |
(24)
N/A
|
(30)
-24%
|
(42)
-38%
|
(48)
-15%
|
(64)
-32%
|
|
| Net Income | ||||||
| Tax Provision |
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
|
| Income from Continuing Operations |
(25)
|
(31)
|
(42)
|
(49)
|
(64)
|
|
| Net Income (Common) |
(25)
N/A
|
(31)
-24%
|
(42)
-38%
|
(49)
-15%
|
(64)
-32%
|
|
| EPS (Diluted) |
-0.09
N/A
|
-0.12
-33%
|
-0.15
-25%
|
-0.16
-7%
|
-0.2
-25%
|
|
Switch to:
Switch to:
See Also
Discover More
